发明名称 Growth differentiation factor 11 (GDF-11) for treatment of diastolic heart failure
摘要 The technology described herein relates to treatments for, e.g., diastolic heart failure, cardiac hypertrophy, and related conditions.
申请公布号 US9434779(B2) 申请公布日期 2016.09.06
申请号 US201314385578 申请日期 2013.03.11
申请人 The Brigham and Women's Hospital, Inc.;President and Fellows of Harvard College 发明人 Lee Richard T.;Loffredo Francesco;Pancoast James;Steinhauser Matthew;Wagers Amy
分类号 A61K38/00;A61K38/16;A61K38/17;A61K38/18;C07K14/51;C07K14/71;A61K31/7088 主分类号 A61K38/00
代理机构 Nixon Peabody LLP 代理人 Nixon Peabody LLP
主权项 1. A method of treating an age-related cardiac hypertrophy, the method comprising administering to a mammalian subject a composition comprising a mammalian GDF11 polypeptide, whereby the composition increases the level of Growth Differentiation Factor 11 (GDF11) polypeptide in the subject; and wherein the composition is administered intraperitoneally; intravenously; subcutaneously: intra-arterially; or intra-coronary arterially.
地址 Boston MA US